Hourglass Capital’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.89M | Sell |
16,665
-1,440
| -8% | -$725K | 1.64% | 23 |
|
|
2025
Q4 | $8.45M | Sell |
18,105
-640
| -3% | -$297K | 1.82% | 13 |
|
|
2025
Q3 | $7.99M | Sell |
18,745
-1,245
| -6% | -$483K | 1.79% | 14 |
|
|
2025
Q2 | $7.66M | Sell |
19,990
-1,205
| -6% | -$434K | 1.89% | 14 |
|
|
2025
Q1 | $7.32M | Sell |
21,195
-427
| -2% | -$137K | 1.92% | 14 |
|
|
2024
Q4 | $6.49M | Buy |
21,622
+5
| +0% | +$1.75K | 1.79% | 20 |
|
|
2024
Q3 | $8.79M | Sell |
21,617
-1,090
| -5% | -$399K | 2.45% | 6 |
|
|
2024
Q2 | $7.3M | Sell |
22,707
-95
| -0.4% | -$30.9K | 2.17% | 12 |
|
|
2024
Q1 | $7.61M | Sell |
22,802
-520
| -2% | -$159K | 2.29% | 9 |
|
|
2023
Q4 | $6.31M | Sell |
23,322
-770
| -3% | -$190K | 2.03% | 15 |
|
|
2023
Q3 | $5.93M | Sell |
24,092
-373
| -2% | -$102K | 2.09% | 14 |
|
|
2023
Q2 | $7.42M | Sell |
24,465
-635
| -3% | -$177K | 2.59% | 5 |
|
|
2023
Q1 | $6.62M | Sell |
25,100
-935
| -4% | -$238K | 2.39% | 10 |
|
|
2022
Q4 | $6.25M | Sell |
26,035
-20
| -0.1% | -$4.48K | 2.2% | 13 |
|
|
2022
Q3 | $4.79M | Buy |
26,055
+90
| +0.3% | +$17.9K | 1.82% | 20 |
|
|
2022
Q2 | $4.36M | Sell |
25,965
-90
| -0.3% | -$19.3K | 1.54% | 26 |
|
|
2022
Q1 | $6.53M | Sell |
26,055
-2,660
| -9% | -$668K | 2.04% | 14 |
|
|
2021
Q4 | $7.38M | Sell |
28,715
-14,680
| -34% | -$3.59M | 2.47% | 9 |
|
|
2021
Q3 | $10.5M | Sell |
43,395
-4,980
| -10% | -$1.22M | 2.87% | 9 |
|
|
2021
Q2 | $10M | Sell |
48,375
-11,210
| -19% | -$2.28M | 2.33% | 9 |
|
|
2021
Q1 | $11.2M | Sell |
59,585
-1,845
| -3% | -$325K | 2.83% | 7 |
|
|
2020
Q4 | $10.1M | Sell |
61,430
-6,395
| -9% | -$935K | 3% | 4 |
|
|
2020
Q3 | $8.46M | Buy |
67,825
+3,350
| +5% | +$415K | 2.85% | 4 |
|
|
2020
Q2 | $6.26M | Buy |
64,475
+22,348
| +53% | +$2.32M | 2.22% | 11 |
|
|
2020
Q1 | $3.79M | Sell |
42,127
-610
| -1% | -$79K | 1.61% | 29 |
|
|
2019
Q4 | $6.32M | Buy |
42,737
+560
| +1% | +$75.2K | 1.71% | 26 |
|
|
2019
Q3 | $5.08M | Buy |
42,177
+300
| +0.7% | +$38.8K | 1.45% | 36 |
|
|
2019
Q2 | $5.66M | Sell |
41,877
-50
| -0.1% | -$6.32K | 1.61% | 31 |
|
|
2019
Q1 | $5.47M | Sell |
41,927
-4,290
| -9% | -$576K | 1.59% | 33 |
|
|
2018
Q4 | $5.75M | Sell |
46,217
-433
| -0.9% | -$58.1K | 1.81% | 25 |
|
|
2018
Q3 | $6.49M | Buy |
46,650
+700
| +2% | +$87.1K | 1.68% | 25 |
|
|
2018
Q2 | $4.71M | Buy |
+45,950
| New | +$4.65M | 1.18% | 39 |
|
Other funds holding HCA
VCM
VPM
Hourglass Capital's HCA Position: Q1 2026 in Review
Hourglass Capital reduced its HCA Healthcare (HCA) stake by 8% in Q1 2026, selling an estimated $725K and leaving 16,665 shares worth $7.89M. The position accounts for 1.64% of the portfolio, ranked #23.
Hourglass Capital first reported a position in HCA in Q2 2018 and has held it in 32 quarters since. The position peaked at $11.2M in Q1 2021. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Hourglass Capital held 16,665 shares of HCA Healthcare worth $7.89M as of Q1 2026.
- Hourglass Capital sold 1,440 HCA Healthcare shares in Q1 2026, an estimated $725K.
- HCA Healthcare made up 1.64% of Hourglass Capital's portfolio in Q1 2026, its #23 holding.
- Hourglass Capital first reported a position in HCA Healthcare in Q2 2018 and has held it in 32 quarters since.
- Hourglass Capital's HCA Healthcare position peaked at $11.2M in Q1 2021.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Hourglass Capital's 13F filing for Q1 2026, filed 4 May 2026.